¼¾ÅÍ ¼Ò°³

¹®¾È°ú ÀÇ·áÁøÀº ü°èÀûÀÎ ½Ã½ºÅÛÀ¸·Î
ÃÖ¼±ÀÇ Áø·á¸¦ Á¦°øÇÕ´Ï´Ù.

Á¶°üÇõ ´ëÇ¥ºÎ¿øÀå

¸Á¸·¼¾ÅÍÀå / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ / Çѱ¹¸Á¸·ÇÐȸÁ¤È¸¿ø

¡¤ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇйڻç°úÁ¤
¡¤ îñ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
- ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¸Á¸·ÀüÀÓÀÇ
¡¤ îñÀÇ·á¹ýÀÎ Çѱæ¾È°úº´¿ø ¸Á¸·¼¾ÅÍ °úÀå
- °¡Å縯°üµ¿ÀÇ°ú´ëÇÐ Á¶±³¼ö
¡¤ ¹Ì±¹ÀÇ»çÀÚ°Ý Ãëµæ(USMLE, New York State, United States)
¡¤ ¹Ì±¹ ´º¿å Ä÷³ºñ¾Æ ÀÇ°ú´ëÇÐ ¾È°ú ¿¬¼ö (Columbia University Medical Center, Edward S. Harkness Eye Institute, New York)
¡¤ ¸¶¸£ÄûÁî ÈĽºÈÄ(Marquis Who¡¯s Who) - ¼¼°è 3´ë Àθí»çÀü, ÀÇÇÐ ¾È°úºÐ¾ß µîÀç
¡¤ îñû¿Í´ë Àǹ«½Ç ±ºÀÇ°ü(¼öµµ¹æÀ§»ç·ÉºÎ)

¼Ò¼ÓÇÐȸ

¡¤ Çѱ¹¸Á¸·ÇÐȸ º¸ÇèÀ§¿ø / ¼ö¿ø½Ã ÀÇ»çȸ ±âȹÀÌ»ç
¡¤ ´ëÇѾȰúÇÐȸ / Çѱ¹Æ÷µµ¸·ÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸(ARVO) Á¤È¸¿ø
¡¤ ¹Ì±¹ Journal of Clinical & Medical Images ³í¹®½É»çÀ§¿ø
¡¤ ¼ö¿ø½Ã ¾Æµ¿ÀÇ·áÁö¿ø»ç¾÷ ºÎÀ§¿øÀå

ÁÖ¿äÇÐȸ¹ßÇ¥

¡¤ 2014 ARVO in Orlando / 2015 AAO in Las Vegas
¡¤ 2016 ARVO in Seattle / 2016 AAO in Chicago
¡¤ 2017 ASCRS in Los Angeles / 2017 APVRS in Kuala Lumpur
¡¤ 2016 ´ëÇѾȰúÇÐȸ Çмú»ó / 2017 ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ¿ì¼ö¿¬±¸ÀÚ»ó (APVRS)

ÁÖ¿ä³í¹® : (SCI ³í¹® Á¦1ÀúÀÚ,Ã¥ÀÓÀúÀÚ¸¸ ±âÀç,Àü¼¼°è Top3 ¾È°ú³í¹® 10¿©Æí, ¸ñ·Ï÷ºÎ)

¡¤ ¸Á¸·³»Ãþ ºÒ±ÔÄ¢ Áö¼ö¸¦ ÀÌ¿ëÇÑ ¸Á¸·Àü¸·ÀÇ ¿¹ÈÄ ¿¹Ãø - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·µ¿¸ÆÆó¼â ȯÀÚÀÇ Ç÷Àü ¾ç»ó ºÐ¼® - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·ºÐÁöÁ¤¸ÆÆó¼â ȯÀÚÀÇ ³úÇ÷°ü ³ªÀÌ ºÐ¼® - ¹Ì±¹½Ã°úÇÐÇÐȸÀú³Î(IOVS) 2017
¡¤ ¸Á¸·¹Ú¸® ȯÀÚÀÇ ¼ö¼ú ÈÄ ±¼Àý°ª º¯È­ - ¹Ì±¹¾È°úÀú³Î(AJO) 2014
- ±× ¿Ü 10¿©Æí Àú¼ú

ÃÖ±Ù SCI ³í¹® ¸ñ·Ï (Á¦ 1ÀúÀÚ, Ã¥ÀÓÀúÀÚ¸¸ ±âÀç)

1. Kim MS, Moon JH, Lee MW, Cho KH (2022), Analysis of postoperative intraocular pathologies in patients with mature cataracts. PLoS ONE 17(1): e0263352.

2. Cho KH, Park SJ, Cho JH, Woo SJ, Park KH. Inner-retinal Irregularity Index Predicts Postoperative Visual Prognosis in Idiopathic Epiretinal Membrane. Am J Ophthalmol. 2016 Aug;168:139-49

3. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. Ischemic Injury of the Papillomacular Bundle Is a Predictive Marker of Poor Vision in Eyes with Branch Retinal Artery Occlusion. Am J Ophthalmol. 2016 Feb;162:107-120

4. Cho KH, Park IW, Kwon SI. Changes in postoperative refractive outcomes following combined phacoemulsification and pars plana vitrectomy for rhegmatogenous retinal detachment. Am J Ophthalmol. 2014 Aug;158(2):251-256

5. Cho KH, Park SJ, Woo SJ, Park KH. Correlation between Inner-retinal changes and outer-retinal damage in patients with idiopathic epiretinal membrane. Retina 2017 Oct 23.

6. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4589-98

7. Cho KH, Kim CK, Woo SJ, Park KH, Park SJ. Cerebral Small Vessel Disease in Branch Retinal Artery Occlusion. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5818-5824.

8. Cho KH, Kim CK, Oh K, Oh SW, Park KH, Park SJ. Retinal Vein Occlusion as the Surrogate Marker for Premature Brain Aging in Young Patients. Invest Ophthalmol Vis Sci. 2017 May 1;58(6).

9. Cho KH, Kim J, Choi DG, Lee JY. Do the primary surgical option for basic-type exotropia cause differences in distance-near discrepancy of recurrent exotropia after surgery? PLoS One. 2019 Aug 19;14(8)

10. Cho KH, Kim HW, Choi DG, Lee JY. Type of the recurrent exotropia after bilateral rectus recession for intermittent exotropia. BMC Ophthalmol. 2016 Jul 8;16:97

11. Cho KH, Lee JY Correction of Hypertropia Coexisting with Intermittent Exotropia, J Korean Ophthalmol Soc 2014;55(12):1883-1889

12. Cho KH, Lee MJ A Case of Canaliculocele Treated with Punctoplasty and Marsupialization J Korean Ophthalmol Soc 2014;55(6):898-901

¹ÚÀ¯Á¤ ¿øÀå

ÀÇÇм®»ç / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ

¡¤ ¼­¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç ¿Ü·¡Á¶±³¼ö
¡¤ ¼­¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
¡¤ ¼­¿ï¾Æ»êº´¿ø ¾È°ú ÀÓ»ó ÀüÀÓ°­»ç
¡¤ ¼­¿ï¾Æ»êº´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ ¼­¿ï¾Æ»êº´¿ø ¼ö·ÃÀÇ
¡¤ ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ´ëÇпø ¾È°úÇÐ ¼®»çÇÐÀ§ ¼ö·á
¡¤ ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷

¼Ò¼ÓÇÐȸ

¡¤ ´ëÇѾȰúÇÐȸ
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO)
¡¤ À¯·´¸Á¸·ÇÐȸ (EURETINA)
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¯¸®Ã¼¸Á¸·ÇÐȸ (APVRS)

ÁÖ¿äÇÐȸ¹ßÇ¥ (1ÀúÀÚ ¹ßÇ¥)

¡¤ 2017 ¹Ì±¹¾È°úÇÐȸ (ARVO) in Baltimore
¡¤ 2019 À¯·´¸Á¸·ÇÐȸ (EURETINA) in Paris
¡¤ 2019 ¾Æ½Ã¾Æ-ÅÂÆò¾ç À¯¸®Ã¼ ¸Á¸·ÇÐȸ (APVRS) in Shanghai

ÁÖ¿ä³í¹® (1ÀúÀÚ)

1. Park YJ, Lee S, Yoon YH. One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy. Graefes Arch Clin Exp Ophthalmol 2022
2. Hess K, Park YJ, Kim H-A, et al. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging. Ophthalmology Retina2022.
3. Park YJ, Lim HT. A Case of Leber Hereditary Optic Neuropathy Showing Optic Disc Hyperfluorescence. J Korean Ophthalmol Soc2019;60(1):96-101.
4. Park YJ, Son GS, Kim YJ, Kim JG, Yoon YH, Lee JY. Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes. J Korean Ophthalmol Soc2018;59(12):1142-1151.

Áø±â¿ø ¿øÀå

¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ

¡¤ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç ÀÓ»ó°­»ç
¡¤ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¸Á¸· ÀüÀÓÀÇ
¡¤ ±è¾È°úº´¿ø ¸Á¸·º´¿ø ±³¼ö
¡¤ ¹Ì±¹ ´º¿å Ä÷³ºñ¾Æ ÀÇ°ú´ëÇÐ ¿¬¼ö (Columbia University Medical Center, New York)
¡¤ °ø±º ¼ö¿ø Á¦10ÀüÅõºñÇà´Ü Ç×°øÀǹ«´ë´ë Áø·á½ÇÀå ¹× ¾È°ú°úÀå
¡¤ ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø ¾È°ú Àü°øÀÇ

¼Ò¼ÓÇÐȸ

¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ (AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸ (ARVO) Á¤È¸¿ø
¡¤ À¯·´¸Á¸·ÇÐȸ (EURETINA) Á¤È¸¿ø

ÁÖ¿äÇÐȸȰµ¿

¡¤ 2016 ARVO in USA, Seattle
¡¤ 2013 ´ëÇѾȰúÇÐȸ Ãá°èÇÐȸ Æ÷½ºÅÍ ¹ßÇ¥, Ãß°èÇÐȸ ±¸¿¬ ¹ßÇ¥
¡¤ 2014 ´ëÇѾȰúÇÐȸ Ãá°èÇÐȸ ±¸¿¬ ¹ßÇ¥, Ãß°èÇÐȸ ±¸¿¬, Æ÷½ºÅÍ ¹ßÇ¥
¡¤ 2015 ´ëÇѾȰúÇÐȸ Ãá°èÇÐȸ Æ÷½ºÅÍ ¹ßÇ¥, Ãß°èÇÐȸ ±¸¿¬ ¹ßÇ¥
¡¤ 2021 ´ëÇѾȰúÇÐȸ Ãá°èÇÐȸ ±¸¿¬ ¹ßÇ¥, Ãß°èÇÐȸ ±¸¿¬ ¹ßÇ¥
¡¤ 2022 ´ëÇѾȰúÇÐȸ Ãß°èÇÐȸ ±¸¿¬ ¹ßÇ¥

ÁÖ¿ä³í¹® (1ÀúÀÚ)

1. Jin KW, Bae SH, Park YJ, Park KH. NASAL CROWDING AND NASAL TILTING OF THE MACULA AFTER EPIRETINAL MEMBRANE SURGERY. Retina. 2022;42:2284-2293.

2. Jin KW, Woo SJ, Park KH. Efficacy and safety of primary posterior capsulotomy during phaco-vitrectomy for epiretinal membrane. BMC Ophthalmol. 2022;22:4.

3. Jin KW, Kim JH, Park JY, Park SJ, Park KH, Lee JY, Woo SJ. Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Sci Rep. 2021;11:14623.

4. Jin KW, Joo K, Woo SJ. Clinical Characterization of Korean Patients with Pseudoxanthoma Elasticum and Angioid Streaks. Genes (Basel). 2021;12:1207.

5. Jin KW, Lee JY, Rhiu S, Choi DG. Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy. PLoS One. 2019;14: e0215297.

6. Jin KW, Lee YP, Choi DG. Surgical outcomes according to distance between preplaced suture and muscle insertion in lateral rectus recession. Eur J Ophthalmol. 2018;28: 253-258.

7. Jin KW, Shin YJ, Hyon JY. Effects of chalazia on corneal astigmatism : Large-sized chalazia in middle upper eyelids compress the cornea and induce the corneal astigmatism. BMC Ophthalmol. 2017;17: 36.

8. Jin KW, Ro JW, Shin YJ, Hyon JY, Wee WR, Park SG. Correlation of vitamin D levels with tear film stability and secretion in patients with dry eye syndrome. Acta Ophthalmol. 2017;95: e230-e235.

9. Jin KW, Choi DG. Outcome of two-muscle surgery for large-angle intermittent exotropia in children. Br J Ophthalmol. 2017;101: 462-466.

10. Ki Won Jin, Ka Young Yi. Research on the Perceptions of Low Vision Rehabilitation. J Korean Ophthalmol Soc 2016;57: 634-641.

11. Jin KW, Kim E, Kim H, Bae SH. Klebsiella Endophthalmitis as Retinal Vasculitis with Prostatic Abscess. Optom Vis Sci. 2015;92: e158-160.

12. Jin KW, Jeon HS, Hyon JY, Wee WR, Suh W, Shin YJ. A case of fungal keratitis and onychomycosis simultaneously infected by Trichophyton species. BMC Ophthalmol. 2014;14: 90.

Àåºñ¼Ò°³

Ophthalmic
Microscope Proveo 8

¡¤¼¼°è ÃÖ°í »ç¾çÀÇ ¾È°ú ¹Ì¼¼¼ö¼ú Çö¹Ì°æ

¡¤ÀÚ¿¬±¤¿¡ °¡±î¿î Á¦³í ¶óÀÌÆ®·Î ȯÀÚ ½Ã·Â º¸°í

¡¤¾È°ú Çö¹Ì°æ ÃÖÃÊ·Î ¸Á¸·±¼Àý±â ³»Àå

¡¤¼ö¼ú ½Ã°£ ´ÜÃà + ¾ÈÁ¤¼º°ú Á¤È®¼º Çâ»ó

OPMI Lumera 700
(·ç¸Þ¶ó700)

´ëÇк´¿ø±Þ ¹Ì¼¼¼ö¼ú Çö¹Ì°æ

¼¾Ã߸®¿Â

¼¼°è ÃÖÃÊ ÀÎÅÚ¸®ÀüÆ® ÇÁ¸®¹Ì¾ö ¹é³»Àå¼ö¼ú Àåºñ

ÄܽºÅ»·¹À̼Ç

Àü¼¼°è °¡Àå Áøº¸µÈ ±â¼úÀÇ Áý¾àü

Heidelberg
spectralis OCT

¾È±¸ »ýü Á¶Á÷ÀÇ ´ÜÃþ ¿µ»ó ¹× Ⱦ´Ü¸éÀ» CT³ª MRIÀÇ 10¹è ÀÌ»ó ¿ì¼öÇÑ Çػ󵵷Π°Ë»çÇÒ ¼ö Àִ ȹ±âÀûÀÎ Àåºñ·Î ´«ÀÇ ¸Á¸·, ¸Æ¶ô¸· Áúȯ µî¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Á¤¹Ð °Ë»ç°¡ °¡´ÉÇÕ´Ï´Ù.

´ëÇü ´ëÇÐ º´¿ø¿¡¼­¸¸ »ç¿ëÇÏ°í ÀÖ´Â Àåºñ·Î Áø´Ü Àåºñ Áß °¡Àå ¾ÈÀüÇÏ°í ºü¸£°Ô ¸¹Àº Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

±¤°¢ ¾ÈÀú Ä«¸Þ¶ó

»êµ¿ ¾øÀÌ 200µµ ¹üÀ§ÀÇ ¸Á¸· ´ëºÎºÐÀ» ÃÔ¿µÇÏ¿© ÁÖº¯ºÎ ¸Á¸· ¿­°ø, ¸Á¸· ¹Ú¸®, ´ç´¢¸Á¸·º´ÁõÀÇ Á¶±â Áø´ÜÀÌ °¡´ÉÇÕ´Ï´Ù.

OCT Angiography SPECTRALIS

ÀÚ°¡Çü±¤¾ÈÀúÃÔ¿µ, ¸Á¸·´ÜÃþÃÔ¿µ, ½Ã½Å°æ¼¶À¯ÃþµÎ²², °¢¸·µÎ²² ÃøÁ¤À¸·Î ´Ù¾çÇÑ ¸Á¸·Áúȯ ¹× ³ì³»Àå, °¢¸·ÁúȯÀ» Áø´ÜÇÏ´Â °Ë»çÀåºñ·Î, Á¶¿µÁ¦ Á¤¸ÆÁֻ簡 ÇÊ¿äÇÏÁö¾Ê¾Æ ¾ÈÀüÇÏ°í ºü¸£°Ô ¸Á¸·°Ç°­À» È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸Á¸· ±â´É ÁöÇüµµ °Ë»ç, ½ÃÀ¯¹ß ¸Á¸·ÀüÀ§µµ °Ë»ç(ERG, VEP)

´«À¸·Î È®ÀεÇÁö ¾Ê´Â ½Ã½Å°æÀÇ ±â´É°ú ¸Á¸·ÀÇ ±â´ÉÀ» °Ë»çÇÏ¿© ¹é³»Àå ¼ö¼ú Àü ½Ã½Å°æ ¹× ¸Á¸·ÀÇ Áúȯ À¯¹«¿Í ½Ã·ÂÀÇ ÁúÀ» °´°üÀûÀ¸·Î Æò°¡ÇÏ¿© ¼ö¼ú °á°ú ¹× ¸¸Á·µµ¸¦ ³ôÀÌ°íÀÚ ÇÏ´Â °Ë»çÇÕ´Ï´Ù.

Æò»ý°ü¸®½Ã½ºÅÛ

¹®¾È°ú´Â Áø·á¿Í ¼ö¼úÀ» ¹ÞÀ¸½Å ºÐµéÀÇ ´«°Ç°­À» ÁöÄѵ帮±âÀ§ÇØ ´Ù¾çÇÑ ÇÁ·Î±×·¥À» Á¦°øÇÏ¿© µå¸³´Ï´Ù.

1:1ÀÇ·áÁø
Ã¥ÀÓÁø·á Á¦µµ
¼ö¼úÀ» ÁýµµÇÑ ÀÇ·áÁøÀÌ Á÷Á¢ ȯÀÚÀÇ ´« °Ç°­À» È®ÀÎÇÏ°í º¸ÁõÇÕ´Ï´Ù.
¼ö¼ú ÈÄ ÄÉ¾î ¼­ºñ½º ¿ø³» °í°´°ü¸®ÆÀÀÌ ¼ö¼ú ÈÄ ÇØÇÇÄÝ ¹× ´ÙÀ½ ³»¿ø ¿¹¾à ¾È³»¸¦ µ½°í ÀÖ½À´Ï´Ù.
Á¤±â °ËÁø Á¦µµ Á¤±âÀûÀÎ °ËÁø ÇÁ·Î±×·¥À¸·Î ´Ù¾çÇÑ ¾ÈÁúȯÀ» Á¶±â¹ß°ß, Á¶±âÄ¡·áÇÕ´Ï´Ù.